Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by...

FDA Drug Recall #D-0771-2021 — Class III — August 5, 2021

Recall Summary

Recall Number D-0771-2021
Classification Class III — Low risk
Date Initiated August 5, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hikma Pharmaceuticals USA Inc.
Location Cherry Hill, NJ
Product Type Drugs
Quantity 1,152 vials

Product Description

Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01

Reason for Recall

Labeling: Not elsewhere classified: Mislabeling

Distribution Pattern

USA nationwide

Lot / Code Information

BL0018

Other Recalls from Hikma Pharmaceuticals USA Inc.

Recall # Classification Product Date
D-0551-2025 Class II Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL via... Jul 22, 2025
D-0635-2024 Class I Acetaminophen Injection, 1,000 mg per 100 mL (1... Jul 8, 2024
D-0392-2024 Class II Infumorph (Preservative-free Morphine Sulfate S... Mar 12, 2024
D-0574-2023 Class II Lorazepam Injection, USP, 2mg/mL, 1 mL vial (ND... May 11, 2023
D-0090-2023 Class II Ganciclovir for Injection, USP, 500mg per vial,... Dec 16, 2022

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.